## UHS: Universal Health Services, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -5.1% below STRENGTH zone (4.0-10.0%); PEG 1.87 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($212.56)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Community Health Systems Stock Falls 7% Amid Debt & Other Pressures**
- Source: Yahoo Finance | 20251209T113800 | Neutral | Relevance: 75%
-  Shares of Community Health Systems (CYH) fell 7% despite a strong recent quarter, driven by concerns over its heavy debt load and uneven patient demand. The company's high net-debt-to-EBITDA ratio and projected negative earnings for 2026 are major investor concerns, even as it sells non-core assets to raise cash. CYH currently holds a Zacks Rank #3 (Hold) and trades at a significantly lower forward price-to-sales ratio compared to its industry average.

**2. HCA, Tenet, UHS receive FTC letters over noncompete agreements**
- Source: Modern Healthcare | 20251210T110555 | Neutral | Relevance: 70%
-  Three major healthcare providers, HCA, Tenet, and UHS, have received letters from the Federal Trade Commission (FTC) regarding their use of noncompete agreements. This action highlights the ongoing scrutiny of such agreements in the healthcare industry and their potential impact on competition and employee mobility. The article also touches upon other healthcare-related news, including new GOP health bills and insurance concerns.

**3. Universal Health Realty (NYSE: UHT) lifts payout by $0.005 to $0.745 per share**
- Source: Stock Titan | 20251210T210938 | Neutral | Relevance: 61%
-  Universal Health Realty Income Trust (NYSE: UHT) announced that its Board of Trustees voted to increase the quarterly dividend by $0.005, raising it to $0.745 per share. The dividend will be paid on December 31, 2025, to shareholders of record as of December 22, 2025. Universal Health Realty Income Trust is a real estate investment trust specializing in healthcare and human service facilities, with 76 investments across 21 states.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Guggenheim | $274 | $253 | +8% |
| 2025-11-13 | Wells Fargo | $259 | $249 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Guggenheim | main | Buy |
| 2025-11-13 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($11.07M) |
| Sells | 3 ($30.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (-3.4%)
- First Eagle Investme: 8.4% (+0.0%)
- Blackrock Inc.: 8.0% (-11.9%)
- State Street Corpora: 4.7% (-3.1%)
- FMR, LLC: 3.8% (+0.1%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.5% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $31M sold (3 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.87 elevated, pricing in significant growth expectations. Analyst sentiment positive (2 raises, avg +6%). Insider selling cluster ($30.5M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $14.3B |
| Beta | 1.27 |
| 52W Range | $152.33 - $246.33 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.87 |
| Forward P/E | 9.6 |
| Current P/E | 10.4 |
| YoY Growth | 8.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -2.6% to -5.1% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.1pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.18x) but short-term weakness (below SMA20). MACD histogram bearish (-2.44), momentum weakening. RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.08% (CS: 11) | Weak |
| RSI_14 | 46.1 | Neutral |
| MACD Histogram | -2.44 | Bearish |
| vs SMA20 | 0.970x | Below |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 1.182x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $224.58
- **Stop Loss:** $212.56 (5.4% risk)
- **Target:** $236.60 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 114
- **Position Value:** $25,602.12
- **Portfolio %:** 25.60%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-25 (Est: $5.89)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.95 | $5.69 | +14.9% |
| 2025Q2 | $4.96 | $5.35 | +8.0% |
| 2025Q1 | $4.36 | $4.84 | +11.1% |
| 2024Q4 | $4.18 | $4.92 | +17.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*